Plain-English translation of NCT05034991 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Endometrial cancer is becoming more common, and doctors want to better understand what affects how patients do after treatment. This study uses ultrasound imaging — a safe, non-invasive tool — to measure blood flow in the uterine lining before surgery. Researchers believe these blood flow patterns may help predict which patients will have better or worse outcomes, potentially guiding future treatment decisions.
Currently, doctors don't have a clear way to predict how individual endometrial cancer patients will respond to treatment. By studying blood flow patterns before surgery, this research aims to find a simple, painless imaging tool that could help doctors better understand each patient's cancer and plan more personalized care.
You likely qualify if…
You likely don't qualify if…
As a participant, you would undergo ultrasound imaging of your uterus before your scheduled surgery. The ultrasound is painless and non-invasive — similar to a standard pregnancy ultrasound. Researchers will measure the blood flow patterns in your uterine lining and track how you do after surgery to see if there's a connection between these patterns and your recovery.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Taiwan
Enrollment target
~75 participants
Started
January 2021
Primary completion
December 2029
Age range
20 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in March 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sheng-Mou Hsiao, MD
Far Eastern Memorial Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.